comprehensive -WSS

comprehensive

author：focus 2025-10-01 14:14:50 - browse：8

Two people shake hands over a wall with dollar signs floating above their heads. -- health business coverage from STAT — Adobe

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. Congratulations on almost making it to the end of the week! For that, I have a little treat for you at the bottom of the newsletter.

But first, the biotech news of the day.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： New oral drug delivery patch is modeled after octopus tentacles

hotspot

explore

WSS

Traditional Chinese medicine benefits explored in new JAMA study

Chimpanzees, like humans and whales, get menopause: Study

Telehealth options flood the market as retailers push virtual care

Readout Newsletter: New research from Sanofi, Regeneron, etc.

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Medtronic CEO on promising devices for diabetes, hypertension

focus

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Experts study whether long Covid risk adds up with each reinfection

BioMarin wins approval for gene therapy to treat hemophilia A

FDA has safety concerns on CRISPR

FDA approval of Sarepta Duchenne genetic therapy gives me hope

European officials brace for rough respiratory virus season

Moonlake's readout produced a cash windfall. Risks remain

New oral drug delivery patch is modeled after octopus tentacles

Medicare proposal to cover medical devices draws a mixed reaction

Congress extends some pandemic preparedness programs

hotspot

RSV injection headlines need to be accurate for good uptake

Readout Newsletter: XBI biotech index, Akero Therapeutics

The FDA weighs the risks of candy

RSV injection headlines need to be accurate for good uptake

The stability of $0 premiums in Medicare Advantage

Health insurers' Q3 question: how much care are people getting?

focus

hotspot

explore

Wikipedia